A major advance in cancer study is emerging with the use of nanobodies to re-engage mutated p53. This essential tumor inhibitor protein is frequently disabled in several types of cancer, causing uncontrolled tissue https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research